Consolidated income grew 20.6% year-on-year to ₹7,044 crore, from ₹5,842 crore in Q1 FY26.
Earnings earlier than curiosity, tax, depreciation and amortisation (EBITDA) elevated 28.2% year-on-year to ₹1,092 crore, in contrast with ₹852 crore a yr in the past. The EBITDA margin stood at 15.5%, in contrast with 14.6% within the year-ago quarter.
Apollo Hospitals’ internet revenue was above the CNBC-TV18 ballot estimate of ₹553 crore. Income additionally got here in forward of the ballot estimate of ₹6,923 crore. EBITDA was larger than the CNBC-TV18 ballot estimate of ₹1,038 crore, whereas the EBITDA margin was forward of the estimated 15%.
ALSO READ | Apollo Hospitals shares may rally 33% from current levels; Citi cites attractive valuations
Healthcare Providers
Apollo Hospitals’ healthcare companies income grew 22% year-on-year to ₹3,567 crore in Q1 FY27, from ₹2,935 crore in Q1 FY26. Earnings earlier than curiosity, tax, depreciation and amortisation (EBITDA) rose 20% to ₹862 crore from ₹718 crore, with the EBITDA margin at 24%. Revenue after tax (PAT) elevated 25% to ₹480 crore from ₹384 crore.
The income development was pushed by a strong improve in volumes in scientific specialties and high-complexity scientific work. As of June 30, 2026, Apollo Hospitals had 8,352 working beds throughout its community, excluding Apollo Well being and Life-style Restricted (AHLL) and managed beds. General occupancy stood at 70%, in contrast with 65% in Q1 FY26.
The brand new hospitals with a mixed working capability of 380 beds in Monetary District, Sonarpur, Pune and Delhi Oncology, commissioned in This fall FY26, together with the Sarjapur facility launched in Q1 FY27, reported a mixed EBITDA lack of ₹38 crore in Q1 FY27.
Regional Hospital Efficiency
In Tamil Nadu, income grew 16%, inpatient (IP) volumes elevated 13%, and common income per affected person (ARPP) rose 5% to ₹2,13,309. General occupancy stood at 1,404 beds, or 70%, in contrast with 1,261 beds, or 62%, in Q1 FY26.
In Andhra Pradesh and Telangana, income elevated 31%, IP volumes rose 25%, and ARPP grew 7% to ₹1,94,605. Occupancy elevated to 948 beds, or 67%, from 813 beds, or 63%, a yr in the past.
ALSO READ | Apollo Hospitals beats the Street, declares dividend of ₹10 as net profit surges 33%
Karnataka income grew 21%, whereas IP volumes rose 10% and ARPP elevated 12% to ₹1,96,748. Occupancy stood at 578 beds, or 70%, in contrast with 534 beds, or 69%, in Q1 FY26.
Within the Japanese area, income elevated 20%, IP volumes rose 12%, and ARPP grew 9% to ₹1,58,952. Occupancy stood at 1,460 beds, or 76%, in contrast with 1,301 beds, or 71%, a yr in the past.
Western area income grew 28%, IP volumes elevated 17%, and ARPP rose 10% to ₹1,73,128. Occupancy stood at 543 beds, or 58%, in contrast with 465 beds, or 52%, in Q1 FY26.
Within the Northern area, income elevated 16%, IP volumes rose 6%, and ARPP grew 10% to ₹1,79,989. Occupancy stood at 895 beds, or 73%, in contrast with 847 beds, or 70% a yr in the past.
Apollo Expands Hospital Capability
Apollo Hospitals launched its 180-bed hospital in Sarjapur, Bengaluru, throughout Q1 FY27. The Gurugram facility stays on observe for commissioning in Q3 FY27.
ALSO READ | Apollo Hospitals to add 850 more beds as expansion pipeline strengthens: MD Suneeta Reddy
The corporate additionally introduced enlargement of its present hospital services in Indore and Guwahati by 148 beds and the addition of 4 new hospitals in Indore, Dwarka, Delhi Proton Centre and Ranchi, collectively accounting for 1,200 beds.
With these additions, Apollo Hospitals plans so as to add greater than 5,000 beds over the subsequent 5 years, together with 4,700 census beds. The Worldwide Affected person Providers division recorded 26% year-on-year income development in the course of the quarter.
Apollo Well being and Life-style
Apollo Well being and Life-style Restricted (AHLL) reported income of ₹499 crore, up 15% year-on-year from ₹435 crore. EBITDA elevated to ₹59 crore from ₹40 crore, with a margin of 12%. PAT loss narrowed to ₹1 crore from a lack of ₹8 crore in Q1 FY26. Diagnostics income stood at ₹200 crore, whereas Spectra income was ₹80 crore.
Apollo HealthCo
Apollo HealthCo reported income of ₹2,977 crore, up 20% from ₹2,472 crore in Q1 FY26. EBITDA rose to ₹171 crore from ₹94 crore, with the margin at 6%, whereas PAT elevated to ₹101 crore from ₹57 crore.
Offline pharmacy distribution income stood at ₹2,629 crore, whereas digital platform income was ₹348 crore. Apollo HealthCo added 151 internet new shops in the course of the quarter, taking its community to 7,440 shops.
Apollo 24/7 gross merchandise worth (GMV) stood at ₹535 crore, up 23% year-on-year. The common day by day order run fee throughout pharmacy, diagnostics and consultations, together with inpatient and outpatient referrals, elevated to 70,000 from 64,000 in Q1 FY26.
Dr Prathap C. Reddy, Founder & Chairman, Apollo Hospitals Group, mentioned, “Q1 FY27 marks a robust begin to the yr, constructing on the momentum of FY26. Consolidated income grew 21% year-on-year to Rs 7,043 crore, supported by sturdy efficiency throughout Healthcare Providers, Diagnostics and Retail Well being, and Digital Well being and Pharmacy. The efficiency displays the power of our built-in mannequin and the continued belief that sufferers and their households place in Apollo.
I’m significantly inspired by this efficiency at a time when Indian healthcare is present process an vital transition. India has made outstanding progress in increasing entry to high quality healthcare over the previous 4 many years.
Establishments like Apollo have each the chance and the accountability to contribute to that transformation. The rising burden of non-communicable illnesses and rising want for specialised care require us to maneuver past episodic therapy in direction of a mannequin that connects prevention, early prognosis, superior intervention and long-term care.
Apollo’s built-in healthcare ecosystem is properly positioned to help this shift. Above all, these outcomes replicate the enduring belief that sufferers and their households place in us. That belief stays our best accountability.”
Shares of Apollo Hospitals Enterprise Ltd ended at ₹8,565.00, down by ₹186.00, or 2.13%, on the BSE.
